Save Studies Locally
We can save your selected studies locally in your browser to enhance your experience. This data stays on your device and is not shared with us or third parties. You can clear this data at any time.
A First in Human Study of BAY2701439 to Look at Safety, How the Body Absorbs, Distributes and Excretes the Drug, and How Well the Drug Works in Participants With Advanced Cancer Expressing the HER2 Protein
Description:
In this study, we want to learn how safe and effective the study drug, BAY2701439, is in patients with advanced cancer that has the protein HER2 (Human Epidermal growth factor Receptor 2) and cannot be cured by currently available treatment options.
Sponsor:
BayerGovernment Study Link:
NCT04147819 - Click here to see study onClinicalTrials.gov
Patient Education
Patient Education Not Yet Provided
Publications
Publications Not Yet Provided
Locations
United States 🇺🇸
New York, New York 10065, United States
Baltimore, Maryland 21287, United States
Houston, Texas 77030, United States
St. Louis, Missouri, United States
United Kingdom 🇬🇧
Sutton, Greater London, England, United Kingdom
SO16 6YD, Southampton, Southampton, England, United Kingdom
